Quarterly report pursuant to Section 13 or 15(d)

CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED)

v3.5.0.2
CONSOLIDATED STATEMENTS OF OPERATIONS (UNAUDITED) - USD ($)
3 Months Ended 9 Months Ended
Jul. 31, 2016
Jul. 31, 2015
Jul. 31, 2016
Jul. 31, 2015
Revenue:        
Revenue from patent licensing activities $ 100,000 $ 95,000 $ 100,000 $ 255,000
Settlement with AU Optronics Corporation 9,000,000
Total revenue 100,000 95,000 100,000 9,255,000
Operating costs and expenses:        
Inventor royalties and contingent legal fees 61,720 48,917 61,720 152,861
Litigation and licensing expenses 8,551 32,636 83,713 3,472,908
Amortization of patents 81,324 81,324 243,972 243,972
Marketing, general and administrative expenses (including non-cash stock option compensation expenses of $570,190 and $2,338,299, respectively) 923,289 1,422,844 3,306,305 5,152,489
Total operating costs and expenses 1,074,884 1,585,721 3,695,710 9,022,230
Loss income from operations (974,884) (1,490,721) (3,595,710) 232,770
Interest expense (132,357) (115,981) (383,238) (333,779)
Interest income 3,466 4,523 10,190 14,379
Loss before income taxes (1,103,775) (1,602,179) (3,968,758) (86,630)
Provision for income taxes
Net loss $ (1,103,775) $ (1,602,179) $ (3,968,758) $ (86,630)
Net loss per common share:        
Basic and diluted (in Dollars per share) $ (0.13) $ (0.18) $ (0.45) $ (0.01)
Weighted average common shares outstanding:        
Basic and diluted (in Shares) 8,745,423 8,762,540 8,736,167 8,773,279